NCT06361992View on ClinicalTrials.gov

Efficacy and Safety of Blue Cap for the Treatment of Atopic Dermatitis in Children

PHASE3CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

March 15, 2022

Primary Completion Date

September 15, 2023

Study Completion Date

February 13, 2024

Conditions
Atopic DermatitisAtopic Dermatitis and Related ConditionsAtopic Dermatitis EczemaAtopic Dermatitis \(AD\)
Interventions
OTHER

Blue Cap Foam

Application regimen: Blue Cap foam 100 ml, Activated Piroctone Olamine (Foam, label 100 ml), Catalysis S.L. Madrid must be applied twice a day on all affected areas. The application is to be continued for 30 days, after which the patients stop using the foam until the final assessment at day 45.

Trial Locations (3)

11000

City Institute for Skin and Venereal Diseases Belgrade, Belgrade

University of Belgrade Faculty of Medicine, University Clinical Center of Serbia, Belgrade

18108

University of Niš Faculty of Medicine, Department of Dermatology and Venereology, University Clinical Center of Niš, Niš

All Listed Sponsors
lead

Catalysis SL

INDUSTRY